Publications by authors named "Todd Boland"

Claim this Profile
I
Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches.
Tushar Jain, Todd Boland, Maximiliano Vásquez

MAbs· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure and Methylation of 35S rDNA in Allopolyploids (2 = 4 = 32, BBDD) and (2 = 6 = 48, AABBDD) and Their Parental Species Show Evidence of Nucleolar Dominance.
Jelena Mlinarec, Ljudevit Luka Boštjančić, Nenad Malenica, Adela Jurković, Todd Boland

Front Plant Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deamidation and isomerization liability analysis of 131 clinical-stage antibodies.
Xiaojun Lu, R Paul Nobrega, Heather Lynaugh, Tushar Jain, Kyle Barlow, Todd Boland

MAbs· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid assessment of oxidation via middle-down LCMS correlates with methionine side-chain solvent-accessible surface area for 121 clinical stage monoclonal antibodies.
Rong Yang, Tushar Jain, Heather Lynaugh, R Paul Nobrega, Xiaojun Lu, Todd Boland

MAbs· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of delayed retention of antibodies in hydrophobic interaction chromatography from sequence using machine learning.
Tushar Jain, Todd Boland, Asparouh Lilov, Irina Burnina, Michael Brown

Bioinformatics· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad epitope coverage of a human in vitro antibody library.
Arvind Sivasubramanian, Patricia Estep, Heather Lynaugh, Yao Yu, Adam Miles, Nadthakarn Boland, Todd Boland

MAbs· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis